Comment
doi: 10.1016/S0140-6736(16)00622-X.
Epub 2016 May 5.
Tocilizumab for systemic sclerosis: implications for future trials
Affiliations
- PMID: 27156931
- DOI: 10.1016/S0140-6736(16)00622-X
Item in Clipboard
Comment
Tocilizumab for systemic sclerosis: implications for future trials
Lancet.
.
No abstract available
Comment on
-
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial.Lancet. 2016 Jun 25;387(10038):2630-2640. doi: 10.1016/S0140-6736(16)00232-4. Epub 2016 May 5. Lancet. 2016. PMID: 27156934 Clinical Trial.
Similar articles
-
Treatment of systemic sclerosis with tocilizumab.Rheumatology (Oxford). 2015 Feb;54(2):371-2. doi: 10.1093/rheumatology/keu435. Epub 2014 Dec 5. Rheumatology (Oxford). 2015. PMID: 25480809 No abstract available.
-
Tocilizumab reduced production of systemic sclerosis-related autoantibodies and anti-cyclic citrullinated protein antibodies in two patients with overlapping systemic sclerosis and rheumatoid arthritis.Scand J Rheumatol. 2018 May;47(3):248-250. doi: 10.1080/03009742.2017.1297482. Epub 2017 May 8. Scand J Rheumatol. 2018. PMID: 28480784 No abstract available.
-
Treatment of myocardial fibrosis in systemic sclerosis with tocilizumab.Rheumatology (Oxford). 2021 Jun 18;60(6):e205-e206. doi: 10.1093/rheumatology/keaa865. Rheumatology (Oxford). 2021. PMID: 33331892 No abstract available.
-
Outcomes of patients with systemic sclerosis treated with tocilizumab: Case series and review of the literature.Best Pract Res Clin Rheumatol. 2018 Aug;32(4):563-571. doi: 10.1016/j.berh.2019.01.011. Epub 2019 Feb 21. Best Pract Res Clin Rheumatol. 2018. PMID: 31174825 Review.
-
Spotlight on tocilizumab and its potential in the treatment of systemic sclerosis.Drug Des Devel Ther. 2016 Aug 29;10:2723-8. doi: 10.2147/DDDT.S99696. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27621593 Free PMC article. Review.
Cited by
-
Safety and efficacy of subcutaneous tocilizumab in systemic sclerosis: results from the open-label period of a phase II randomised controlled trial (faSScinate).Ann Rheum Dis. 2018 Feb;77(2):212-220. doi: 10.1136/annrheumdis-2017-211682. Epub 2017 Oct 24. Ann Rheum Dis. 2018. PMID: 29066464 Free PMC article. Clinical Trial.
-
Parry Romberg disease with En Coup de Sabre Scleroderma: Effect of tocilizumab on periodontal bone inflammation.J Scleroderma Relat Disord. 2021 Jun;6(2):206-210. doi: 10.1177/2397198320975872. Epub 2020 Nov 25. J Scleroderma Relat Disord. 2021. PMID: 35386743 Free PMC article.
-
Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort.RMD Open. 2022 Nov;8(2):e002477. doi: 10.1136/rmdopen-2022-002477. RMD Open. 2022. PMID: 36328401 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
